Zonisamide
- Generic Name
- Zonisamide
- Brand Names
- Zonegran, Zonisade, Zonisamide Mylan
- Drug Type
- Small Molecule
- Chemical Formula
- C8H8N2O3S
- CAS Number
- 68291-97-4
- Unique Ingredient Identifier
- 459384H98V
- Background
Zonisamide is a sulfonamide anticonvulsant used as an adjunctive therapy in adults with partial-onset seizures. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels, leading to a reduction of T-type calcium channel currents or by binding allosterically to GABA receptors. This latter action may inhibit the uptake of the inhibitory...
- Indication
Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. Zonisamide oral suspension is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.
- Associated Conditions
- Partial-Onset Seizures
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.